APA (7th ed.) Citation

MH, A., H, S., MB, M., V, R., KK, W., MS, H., . . . JA, R. (2016). Beta-Lactam Infusion in Severe Sepsis (BLISS): A prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Intensive care medicine, 42(10), 1535. https://doi.org/10.1007/s00134-015-4188-0

Chicago Style (17th ed.) Citation

MH, Abdul-Aziz, et al. "Beta-Lactam Infusion in Severe Sepsis (BLISS): A Prospective, Two-centre, Open-labelled Randomised Controlled Trial of Continuous Versus Intermittent Beta-lactam Infusion in Critically Ill Patients with Severe Sepsis." Intensive Care Medicine 42, no. 10 (2016): 1535. https://doi.org/10.1007/s00134-015-4188-0.

MLA (9th ed.) Citation

MH, Abdul-Aziz, et al. "Beta-Lactam Infusion in Severe Sepsis (BLISS): A Prospective, Two-centre, Open-labelled Randomised Controlled Trial of Continuous Versus Intermittent Beta-lactam Infusion in Critically Ill Patients with Severe Sepsis." Intensive Care Medicine, vol. 42, no. 10, 2016, p. 1535, https://doi.org/10.1007/s00134-015-4188-0.